Enliven Therapeutics, Inc. ELVN
NASDAQ · United States · Health Technology
$46.65+0.81 (+1.77%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | -0.49 | -0.39 | -26.6% | $0 | — | -1.4%$61.11→$60.27 |
| Q1 2026 | 2026-05-07 | -0.38 | -0.44 | +13.6% | — | — | -1.1%$41.20→$40.75 |
| Q4 2025 | 2026-03-03 | -0.48 | -0.47 | -2.1% | — | — | +1.6%$29.50→$29.98 |
| Q3 2025 | 2025-11-12 | -0.32 | -0.43 | +25.6% | — | — | +3.2%$19.64→$20.27 |
| Q4 2024 | 2025-03-13 | -0.46 | -0.52 | +11.5% | — | — | — |
| Q4 2023 | 2024-03-14 | -0.47 | -0.54 | +13.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.